Annexin II overexpression correlates with stromal tenascin‐C overexpression
暂无分享,去创建一个
Y. Nakajima | T Takayama | Y Nakajima | T. Takayama | K Emoto | Y Yamada | H Sawada | H Fujimoto | M Ueno | K Kamada | A Naito | S Hirao | H. Sawada | Yukishige Yamada | S. Hirao | K. Kamada | H. Fujimoto | K. Emoto | A. Naito | Masatou Ueno | Koji Emoto
[1] M. Hollingsworth,et al. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. , 1993, Carcinogenesis.
[2] M. Pinkoski,et al. Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. , 1992, British Journal of Cancer.
[3] M. Jost,et al. Mapping of three unique Ca(2+)-binding sites in human annexin II. , 1992, European journal of biochemistry.
[4] M. McLaughlin,et al. Annexin II and bleeding in acute promyelocytic leukemia. , 1999, The New England journal of medicine.
[5] M. Geisow,et al. The annexin family of calcium-binding proteins. Review article. , 1989, Cell calcium.
[6] C. Kahn,et al. Lipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver. , 1988, The Journal of biological chemistry.
[7] A. Puisieux,et al. Annexin II upregulates cellular levels of p 11 protein by a post-translational mechanism , 1996 .
[8] Norifumi Ueda,et al. Modulation of S‐100 genes response to growth conditions in human epithelial tumor cells , 1997, Pathology international.
[9] T. Sakakura,et al. Co‐expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast , 1997, The Journal of pathology.
[10] K. Koretz,et al. Differential expression of annexins I and II in normal and malignant human mammary epithelial cells. , 1993, Differentiation; research in biological diversity.
[11] J. Paavonen,et al. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. , 1992, American Journal of Pathology.
[12] D.,et al. Regression Models and Life-Tables , 2022 .
[13] S. Cohen,et al. Epidermal growth factor stimulates the phosphorylation of the calcium-dependent 35,000-dalton substrate in intact A-431 cells. , 1985, The Journal of biological chemistry.
[14] R. Chiquet‐Ehrismann,et al. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.
[15] K. Schmid,et al. Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study , 1998, Histochemistry and Cell Biology.
[16] T. Toivonen,et al. Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis , 1996, International journal of cancer.
[17] H. Erickson,et al. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. , 1996, Molecular biology of the cell.
[18] J. Wands,et al. Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. , 1990, Molecular and cellular biology.
[19] J. Glenney,et al. Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[20] B. Bastian. Annexins in cancer and autoimmune diseases , 1997, Cellular and Molecular Life Sciences CMLS.
[21] J. J. Steinberg,et al. Morphologic pattern of tenascin as a diagnostic biomarker in colon cancer , 1997, Journal of surgical oncology.
[22] H. Kawakatsu,et al. Specific expression of tenascin in human colonic neoplasms. , 1993, British Journal of Cancer.
[23] S. Kain,et al. Human multiple tissue western blots: a new immunological tool for the analysis of tissue-specific protein expression. , 1994, BioTechniques.
[24] T. Tsuruo,et al. Expression of platelet‐derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma , 2000, Cancer.
[25] M. Kusakabe,et al. Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. , 1988, Developmental biology.
[26] L. Alberghina,et al. Characterization of the tyrosine phosphorylation of calpactin I (annexin II) induced by platelet-derived growth factor. , 1991, The Biochemical journal.
[27] P. Möller,et al. Tenascin-C tissue concentration in inflammatory and neoplastic diseases of the colon mucosa. , 1997, Anticancer research.
[28] B. Rothhut. Participation of annexins in protein phosphorylation , 1997, Cellular and Molecular Life Sciences CMLS.
[29] Y. Kawarada,et al. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[30] L. Påhlman,et al. Stromal tenascin distribution as a prognostic marker in colorectal cancer. , 1997, British Journal of Cancer.
[31] A. Verstraeten,et al. Tenascin expression in basal cell carcinoma , 1992, The British journal of dermatology.
[32] E. Mackie. Molecules in focus: tenascin-C. , 1997, The international journal of biochemistry & cell biology.
[33] A. Puisieux,et al. Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanisms. , 1996, The Biochemical journal.
[34] T. Sakakura,et al. Combined Analysis of Expression of c‐evbB‐2, Ki‐67 Antigen, and Tenascin Provides a Better Prognostic Indicator of Carcinoma of the Papilla of Vater , 1996, Pancreas.
[35] F. Real,et al. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro , 1998, Oncogene.
[36] S. Shintani,et al. Extracellular matrices expression in invasion area of adenoid cystic carcinoma of salivary glands. , 1997, Cancer letters.
[37] A. Harris,et al. Combined role of tumor angiogenesis, bcl‐2, and p53 expression in the prognosis of patients with colorectal carcinoma , 1999, Cancer.
[38] I. Yada,et al. Expression and degeneration of tenascin-C in human lung cancers. , 1998, British Journal of Cancer.
[39] J. Vishwanatha,et al. Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. , 1992, Cancer research.
[40] I. Virtanen,et al. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[41] J. Browning,et al. Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates. , 1986, The Journal of biological chemistry.
[42] K. Titani,et al. Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin. , 1991, Cancer research.
[43] M. Israel,et al. Annexin II marks astrocytic brain tumors of high histologic grade. , 1994, Oncology research.
[44] Z. Werb,et al. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. , 1994, Molecular biology of the cell.
[45] H. Hidaka,et al. Ca2+ signaling and intracellular Ca2+ binding proteins. , 1996, Journal of biochemistry.
[46] P. Carreira,et al. Survival of patients with colorectal carcinoma , 1999, Cancer.
[47] T. Sakakura,et al. Analysis of tenascin mRNA expression in the murine mammary gland from embryogenesis to carcinogenesis: an in situ hybridization study. , 1997, The International journal of developmental biology.
[48] H. Erickson,et al. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C , 1994, The Journal of cell biology.
[49] J. Vishwanatha,et al. Altered expression of annexin II in human B-cell lymphoma cell lines. , 1996, Biochimica et biophysica acta.
[50] C. Creutz. The annexins and exocytosis. , 1992, Science.